Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for OrthoPediatrics Corp. (KIDS : NSDQ)

• Company Description    OrthoPediatrics Corp. is a medical device company. It markets surgical systems for trauma and deformity, bone fractures and reconstruction procedures. OrthoPediatrics Corp. is based in NEW YORK. Number of Employees: 562

• Price / Volume Information    Yesterday's Closing Price: $19.65 Daily Weekly Monthly 20 Day Moving Average: 127,761 shares Shares Outstanding: 25.07 (millions) Market Capitalization: $492.70 (millions) Beta: 1.06 52 Week High: $33.14 52 Week Low: $16.59 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 2.72% 0.91% 12 Week -2.48% -11.42% Year To Date -15.23% -21.69%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2850 Frontier Drive - Warsaw,IN 46582 USA ph: 574-268-6379 fax: 574-269-3692 philip@gilmartinir.com http://www.orthopediatrics.com

• General Corporate Information    Officers David R. Bailey - President and Chief Executive Officer Fred L. Hite - Chief Financial Officer and Chief Operating Office Mark C. Throdahl - Director Bryan W. Hughes - Director Terry D. Schlotterback - Director Peer Information OrthoPediatrics Corp. (ABMD) OrthoPediatrics Corp. (DMDS) OrthoPediatrics Corp. (CPWY.) OrthoPediatrics Corp. (EQUR) OrthoPediatrics Corp. (ECIA) OrthoPediatrics Corp. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 68752L100 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/05/25 Share - Related Items Shares Outstanding: 25.07 Most Recent Split Date: (:1) Beta: 1.06 Market Capitalization: $492.70 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.24 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.16 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/05/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.34 Price/Cash Flow: - Price / Sales: 2.23 EPS Growth vs. Year Ago Period: 52.17% vs. Previous Quarter: 71.79% Sales Growth vs. Year Ago Period: 15.68% vs. Previous Quarter: 16.54% ROE 06/30/25 - -6.36 03/31/25 - -7.03 12/31/24 - -6.33 ROA 06/30/25 - -4.69 03/31/25 - -5.45 12/31/24 - -5.08 Current Ratio 06/30/25 - 6.66 03/31/25 - 6.19 12/31/24 - 6.98 Quick Ratio 06/30/25 - 3.43 03/31/25 - 2.99 12/31/24 - 3.54 Operating Margin 06/30/25 - -10.28 03/31/25 - -11.95 12/31/24 - -11.35 Net Margin 06/30/25 - -18.92 03/31/25 - -19.15 12/31/24 - -18.47 Pre-Tax Margin 06/30/25 - -19.51 03/31/25 - -19.80 12/31/24 - -20.48 Book Value 06/30/25 - 14.64 03/31/25 - 14.29 12/31/24 - 14.64 Inventory Turnover 06/30/25 - 0.52 03/31/25 - 0.49 12/31/24 - 0.48 Debt-to-Equity 06/30/25 - 0.27 03/31/25 - 0.21 12/31/24 - 0.20 Debt-to-Capital 06/30/25 - 21.34 03/31/25 - 17.27 12/31/24 - 16.94

Powered by Zacks Investment Research ©